Fluoxetine for Maintenance of Remission and to Improve Quality of Life in Patients with Crohn’s Disease: a Pilot Randomized Placebo-Controlled Trial

BACKGROUND AND AIMS: Previous studies have shown that antidepressants reduce inflammation in animal models of colitis. The present trial aimed to examine whether fluoxetine added to standard therapy for Crohn’s disease [CD] maintained remission, improved quality of life [QoL] and/or mental health in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Crohns Colitis
Egile Nagusiak: Mikocka-Walus, Antonina, Hughes, Patrick A., Bampton, Peter, Gordon, Andrea, Campaniello, Melissa A., Mavrangelos, Chris, Stewart, Benjamin J., Esterman, Adrian, Andrews, Jane M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2017
Gaiak:
Short Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5881791/
https://ncbi.nlm.nih.gov/pubmed/27664274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjw165
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak